Stock News

Company Update (NASDAQ:ADHD): Alcobra Ltd. to Present at Two CNS Focused Conferences in April

Alcobra Ltd (NASDAQ:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity …

Company Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Announces Initiation of Phase 1/2 Study of Varlilumab in Combination with Ipilimumab and CDX-1401 in Metastatic Melanoma

Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced the initiation of a Phase 1/2 safety pilot and expansion study examining the investigational combination of varlilumab and …

Stock Update (NASDAQ:CYTX): Cytori Therapeutics Inc and Lorem Vascular Receive Regulatory Clearance in China

Cytori Therapeutics Inc (NASDAQ:CYTX) announced that its exclusive licensee, Lorem Vascular, has been granted regulatory clearance for the Cytori Celution® System by the State Food and …

Stock Update (NASDAQ:ARIA): ARIAD Pharmaceuticals, Inc. Announces Approval of Iclusig (as Ponatinib Hydrochloride) in Canada

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA), today announced that Health Canada has approved the use of Iclusig™ (as ponatinib hydrochloride) in Canada for the treatment of adult patients with all …

Company Update (NASDAQ:CSIQ): Canadian Solar Completes the Sale of the Third Utility Solar Power Plant to RET Capital

Canadian Solar Inc. (NASDAQ:CSIQ), one of the world's largest solar power companies, announced that its wholly owned subsidiary, Canadian Solar Solutions Inc.

Company Update (NASDAQ:CRIS): Curis, Inc. Announces Orphan Drug Designation for CUDC-907 in Diffuse Large B-Cell Lymphoma

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, announced …

Stock Update (NASDAQ:CSIQ): Canadian Solar Inc. Energizes Four Solar PV Plants in the United Kingdom

Canadian Solar Inc. (NASDAQ:CSIQ), one of the world's largest solar power companies, announced that it energized four projects totaling 40.

Company Update (NASDAQ:NKTR): Nektar Therapeutics Announces Receipt of $100 Million Milestone Payment from AstraZeneca

Nektar Therapeutics (NASDAQ:NKTR) announced today that it has received a $100 million payment under a license agreement with AstraZeneca. The cash payment under the Nektar-AstraZeneca …

Stock Update (NASDAQ:CNAT): Conatus Announces Pricing of Public Offering of Common Stock

Conatus Pharmaceuticals Inc. (NADAQ:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, announced today that …

Stock Update (NASDAQ:FCEL): FuelCell Energy Applauds Issuance of Executive Order for Sustainability Planning by the U.S. Federal Government

FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in the design, manufacture, operation and service of ultra‚Äźclean, efficient and reliable fuel cell power plants, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts